The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia
International Journal of Molecular Sciences · 17.03.2023 · 24 (6) · 5734
DOI: 10.3390/ijms24065734 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.03.2023. Verfasst von Claudia Bănescu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Advanced Medical and Pharmaceutical Research, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, …. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Myelodysplastic Syndromes. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Unitatea Executiva Pentru Finantarea Invatamantului Superior a Cercetarii Dezvoltarii si Inovarii, Romanian Ministry of Education and Research.
Abstract (Originalsprache)
Myelodysplastic neoplasm (MDS) represents a heterogeneous group of myeloid disorders that originate from the hematopoietic stem and progenitor cells that lead to the development of clonal hematopoiesis. MDS was characterized by an increased risk of transformation into acute myeloid leukemia (AML). In recent years, with the aid of next-generation sequencing (NGS), an increasing number of molecular aberrations were discovered, such as recurrent mutations in FLT3, NPM1, DNMT3A, TP53, NRAS, and RUNX1 genes. During MDS progression to leukemia, the order of gene mutation acquisition is not random and is important when considering the prognostic impact. Moreover, the co-occurrence of certain gene mutations is not random; some of the combinations of gene mutations seem to have a high frequency (ASXL1 and U2AF1), while the co-occurrence of mutations in splicing factor genes is rarely observed. Recent progress in the understanding of molecular events has led to MDS transformation into AML and unraveling the genetic signature has paved the way for developing novel targeted and personalized treatments. This article reviews the genetic abnormalities that increase the risk of MDS transformation to AML, and the impact of genetic changes on evolution. Selected therapies for MDS and MDS progression to AML are also discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Advanced Medical and Pharmaceutical Research, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540142 Targu Mures, Romania.
- Genetics Department, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania.
- Pediatric Department, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania.
ORCID-Profile: Claudia Bănescu, Florin Tripon, Carmen Muntean
Förderung
- Unitatea Executiva Pentru Finantarea Invatamantului Superior a Cercetarii Dezvoltarii si Inovarii
- Romanian Ministry of Education and Research
Zitieren
APA
Bănescu, C., Tripon, F., & Muntean, C. (2023). The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia. International Journal of Molecular Sciences, 24(6), 5734. https://doi.org/10.3390/ijms24065734
Vancouver
Bănescu C, Tripon F, Muntean C. The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia. International Journal of Molecular Sciences. 2023;24(6):5734. doi:10.3390/ijms24065734
BibTeX
@article{Bnescu2023,
author = {Bănescu, Claudia and Tripon, Florin and Muntean, Carmen},
title = {The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {6},
pages = {5734},
doi = {10.3390/ijms24065734}
}
EUVIMED